(Q40877880)

24 September 2017

1 reference

title

Prospects for adoptive T cell therapy (English)

1 reference

24 September 2017

C Yee

1

1 reference

PubMed ID

9368780

24 September 2017

S R Riddell

series ordinal

2

1 reference

PubMed ID

9368780

24 September 2017

P D Greenberg

series ordinal

3

1 reference

24 September 2017

1 October 1997

1 reference

Current Opinion in Immunology

24 September 2017

1 reference

24 September 2017

9

1 reference

24 September 2017

702-708

1 reference

24 September 2017

5

1 reference

Treatment of patients with metastatic melanoma with autologous tumor-infiltrating lymphocytes and interleukin 2

24 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2897%2980052-0

7 January 2021

A Gene Encoding an Antigen Recognized by Cytolytic T Lymphocytes on a Human Melanoma

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2897%2980052-0

7 January 2021

Human gene MAGE-3 codes for an antigen recognized on a melanoma by autologous cytolytic T lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2897%2980052-0

7 January 2021

A peptide recognized by human cytolytic T lymphocytes on HLA-A2 melanomas is encoded by an intron sequence of the N-acetylglucosaminyltransferase V gene

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2897%2980052-0

7 January 2021

A p16INK4a-insensitive CDK4 mutant targeted by cytolytic T lymphocytes in a human melanoma

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2897%2980052-0

7 January 2021

A mutated beta-catenin gene encodes a melanoma-specific antigen recognized by tumor infiltrating lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2897%2980052-0

7 January 2021

The tyrosinase gene codes for an antigen recognized by autologous cytolytic T lymphocytes on HLA-A2 melanomas

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2897%2980052-0

7 January 2021

A new gene coding for a differentiation antigen recognized by autologous cytolytic T lymphocytes on HLA-A2 melanomas

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2897%2980052-0

7 January 2021

Cloning of the gene coding for a shared human melanoma antigen recognized by autologous T cells infiltrating into tumor

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2897%2980052-0

7 January 2021

Identification of a human melanoma antigen recognized by tumor-infiltrating lymphocytes associated with in vivo tumor rejection

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2897%2980052-0

7 January 2021

Utilization of an alternative open reading frame of a normal gene in generating a novel human cancer antigen

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2897%2980052-0

7 January 2021

Detection and quantification of blood-derived CD8+ T lymphocytes secreting tumor necrosis factor alpha in response to HLA-A2.1-binding melanoma and viral peptide antigens

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2897%2980052-0

7 January 2021

Identification of the immunodominant peptides of the MART-1 human melanoma antigen recognized by the majority of HLA-A2-restricted tumor infiltrating lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2897%2980052-0

7 January 2021

Peptide-specific CTL in tumor infiltrating lymphocytes from metastatic melanomas expressing MART-1/Melan-A, gp100 and Tyrosinase genes: a study in an unselected group of HLA-A2.1-positive patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2897%2980052-0

7 January 2021

Identification of epitope mimics recognized by CTL reactive to the melanoma/melanocyte-derived peptide MART-1(27-35)

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2897%2980052-0

7 January 2021

The majority of autologous cytolytic T-lymphocyte clones derived from peripheral blood lymphocytes of a melanoma patient recognize an antigenic peptide derived from gene Pmel17/gp100.

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2897%2980052-0

7 January 2021

A new family of genes coding for an antigen recognized by autologous cytolytic T lymphocytes on a human melanoma

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2897%2980052-0

7 January 2021

Immunophenotyping of melanomas for tyrosinase: implications for vaccine development

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2897%2980052-0

7 January 2021

A tumor escape variant that has lost one major histocompatibility complex class I restriction element induces specific CD8+ T cells to an antigen that no longer serves as a target

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2897%2980052-0

7 January 2021

Loss of a unique tumor antigen by cytotoxic T lymphocyte immunoselection from a 3-methylcholanthrene-induced mouse sarcoma reveals secondary unique and shared antigens

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2897%2980052-0

7 January 2021

Differences in the antigens recognized by cytolytic T cells on two successive metastases of a melanoma patient are consistent with immune selection

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2897%2980052-0

7 January 2021

Immunoselection in vivo: independent loss of MHC class I and melanocyte differentiation antigen expression in metastatic melanoma

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2897%2980052-0

7 January 2021

Serological analysis of Melan-A(MART-1), a melanocyte-specific protein homogeneously expressed in human melanomas

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2897%2980052-0

7 January 2021

Melanoma cells and normal melanocytes share antigens recognized by HLA-A2-restricted cytotoxic T cell clones from melanoma patients

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2897%2980052-0

7 January 2021

Melanocyte lysis by cytotoxic T lymphocytes recognizing the MART-1 melanoma antigen in HLA-A2 patients with Vogt-Koyanagi-Harada disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2897%2980052-0

7 January 2021

An evaluation of the potential to use tumor-associated antigens as targets for antitumor T cell therapy using transgenic mice expressing a retroviral tumor antigen in normal lymphoid tissues

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2897%2980052-0

7 January 2021

Identification of tyrosinase-related protein 2 as a tumor rejection antigen for the B16 melanoma

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2897%2980052-0

7 January 2021

Induction of anti-tumor cytotoxic T lymphocytes in normal humans using primary cultures and synthetic peptide epitopes

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2897%2980052-0

7 January 2021

Role of antigen, CD8, and cytotoxic T lymphocyte (CTL) avidity in high dose antigen induction of apoptosis of effector CTL

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2897%2980052-0

7 January 2021

Selective expansion of high- or low-avidity cytotoxic T lymphocytes and efficacy for adoptive immunotherapy.

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2897%2980052-0

7 January 2021

Identification of potential CTL epitopes of tumor-associated antigen MAGE-1 for five common HLA-A alleles

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2897%2980052-0

7 January 2021

In vitro induction of primary, antigen-specific CTL from human peripheral blood mononuclear cells stimulated with synthetic peptides

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2897%2980052-0

7 January 2021

Dendritic cells pulsed with RNA are potent antigen-presenting cells in vitro and in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2897%2980052-0

7 January 2021

Gene gun and other non-viral approaches for cancer gene therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2897%2980052-0

7 January 2021

CD4+ T cells are required to sustain CD8+ cytotoxic T-cell responses during chronic viral infection

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2897%2980052-0

7 January 2021

Reconstitution of cellular immunity against cytomegalovirus in recipients of allogeneic bone marrow by transfer of T-cell clones from the donor

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2897%2980052-0

7 January 2021

Melanoma-specific CD4+ T cells recognize nonmutated HLA-DR-restricted tyrosinase epitopes

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2897%2980052-0

7 January 2021

Infusions of donor leukocytes to treat Epstein-Barr virus-associated lymphoproliferative disorders after allogeneic bone marrow transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2897%2980052-0

7 January 2021

Gene transfer into humans--immunotherapy of patients with advanced melanoma, using tumor-infiltrating lymphocytes modified by retroviral gene transduction

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2897%2980052-0

7 January 2021

Long-term restoration of immunity against Epstein-Barr virus infection by adoptive transfer of gene-modified virus-specific T lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2897%2980052-0

7 January 2021

Phase I Study of Cellular Adoptive Immunotherapy Using Genetically Modified CD8+ HIV-Specific T Cells for HIV Seropositive Patients Undergoing Allogeneic Bone Marrow Transplant. Fred Hutchinson Cancer Research Center and the University of Washington

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2897%2980052-0

7 January 2021

HSV-TK gene transfer into donor lymphocytes for control of allogeneic graft-versus-leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2897%2980052-0

7 January 2021

Cytoplasmic domains of the interleukin-2 receptor beta and gamma chains mediate the signal for T-cell proliferation.

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2897%2980052-0

7 January 2021

10.1016/S0952-7915(97)80052-0

Identifiers

DOI

1 reference

24 September 2017

1 reference

PubMed ID

9368780